Subscribe

Happy Town Holdings Inc. (HPTN)

USD0.00 +0.00 (+0.00%)
CA OTC Consumer Defensive Household & Personal Products
Address 82 Avenue Road M5R 2H2
Toronto, ON, CA
CEO Michael Stocker
IPO 2012-09-25
ISIN US4113981009

Explore sections of this company profile

Description

Operating through its various subsidiaries, Red Eye Guys Ltd. specializes in creating and manufacturing the Biologix Hair Therapy System. This innovative system includes both a specialized formulation and an administration method to combat Follicle Nutrient Deficiency Syndrome (FNDS). A key element of this system is Biologix Revive, a particular hair formula that is delivered directly to FNDS-compromised follicles via a series of precise, shallow needle injections. The company's therapeutic solution is engineered to address, reverse the effects of, and prevent the onset of FNDS, as well as to treat alopecia areata. Known as Biologix Hair, Inc. until April 2014, the firm subsequently changed its name to Red Eye Guys Ltd. The company is headquartered in Toronto, Canada, and maintains subsidiary operations in Barbados and Panama.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.00 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
523
Beta
4.59
Float Shares
22.86M
Free Float %
40.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +0.00% +0.00% +33.33% +0.00% +33.33% +0.00% -99.93% -99.48% -99.95%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.00
Quality scores
Altman Z-Score
-11.61
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Operational MOAT
✗ Below peers
  • Revenue growth Household & Personal Products: +3.3%
  • EPS growth Household & Personal Products: +8.8%
    +77.6% Q1'21: +98.7% (vs Q1'20)
  • FCF margin FCF growth · Household & Personal Products: +44.8%
  • EBIT margin Household & Personal Products: +9.9%
  • ROIC Household & Personal Products: +8.2%
    -67.1% Q1'21: -1.0% (vs Q1'20)
  • Share dilution Household & Personal Products: +0.2%
    +27.3% Q1'21: 0.0% (vs Q1'20)
  • Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×
    -1.17× Q1'21: -74.92× (vs Q1'20)
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (4.76) × ERP
WACC = 1% × Ke + 99% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Ownership data is not available for this company yet.

Executive team

Top executives
Shares Outstanding
56.86M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Ronald Holland Director and President of Biologix Hair (Canada) Inc 89.9K male
Craig L. Ziering Chairman of Medical Advisory Board and President of Research & Development male
Leila Bloch Vice President of Research & Development and Member of Medical Advisory Board female
Michael Stocker Chief Executive Officer and Director
Peter Wiget Chief Financial Officer male
Todd A. Harrison Chief Legal Counsel male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings reports

Stock splits